PATENT CLAIM ANALYSIS

Application Number: 15764193
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "193000"]

Abstract:
Thalidomide analogs and methods of using the thalidomide analogs are disclosed. Some embodiments of the disclosed compounds exhibit anti-angiogenic and/or anti-inflammatory activity. Certain embodiments of the disclosed compounds are non-teratogenic.

Claim (Index 15):
The method according to  claim 12 , wherein the subject has an inflammatory disorder, the thalidomide analog is non-teratogenic and possesses anti-inflammatory properties, and administering the therapeutically effective amount of the thalidomide analog or pharmaceutically acceptable salt thereof or the therapeutically effective amount of the pharmaceutical composition to the subject treats the inflammatory disorder.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 90.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13153355', '12767647', '10572485', '13498067', '13648625']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7824373643955904
- 35 USC 102 Novelty (BERT): 0.5162970662161357
- Combined Prediction Score: 0.755823334577645
- Mean Citation Score: 257.70049
- Max Citation Score: 277.90332
- Similarity Product: 175.01535073812963

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test